Double layer disc for treatment of diabetes

CHF 68.90
Auf Lager
SKU
MOJIQ1OMR82
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

The present research work was carried out to develop a Bilayer tablet of M.HCl as ER layer and Acarbose as IR layer from their respective SDs. Eudragit RL 100 and RS 100 were used for the preparation of SD of M.HCl enables drug release for upto 12 hrs. Among the different formulations, formulation having Eudragit RL 100 and RS 100 in the ratio of 1:2 (MF8) can be preferred as integrity was maintained. PVP K 30 and PEG 6000 were used for the preparation of SD of Acarbose. Among the different formulations, formulation having Acarbose and PVP K 30 in the ratio of 1:4 (AF3) can be preferred because of maximum drug release and highest correlation coefficient. The analysis by spectral technique (FT-IR) suggested the possibility of hydrogen bonding.

Autorentext

Dr. Ruchi Tiwari is an Associate Professor in Department of Pharmaceutics at the Pranveer Singh Institute of Technology, Kanpur. She has more than 8 books and 13 patents to her credit.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09786204207001
    • Sprache Englisch
    • Größe H220mm x B150mm x T6mm
    • Jahr 2021
    • EAN 9786204207001
    • Format Kartonierter Einband
    • ISBN 6204207008
    • Veröffentlichung 30.09.2021
    • Titel Double layer disc for treatment of diabetes
    • Autor Ruchi Tiwari , Meenakshi Joshi , Gaurav Tiwari
    • Untertitel Double layer disc for diabetes
    • Gewicht 167g
    • Herausgeber LAP LAMBERT Academic Publishing
    • Anzahl Seiten 100
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470